Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Insulin Delivery Feb 14 | 2019New iPump Pathway: Tandem t:slim X2 Approved as First Interoperable PumpPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, SGLT2i Feb 14 | 2019Farxiga LCM and Litigation Update; AZ Q4 '18 Earnings SummaryPurchase Blast
$599
Posted in: Glucagon Feb 12 | 2019Xeris Glucagon to be Branded "Gvoke"; Xeris Issues 5M Additional SharesPurchase Blast
$599
Posted in: Bolus Insulin, Insulin Delivery Feb 11 | 2019New Lilly and Novo uRAI pump trials: URLi ‘PRONTO-Pump-2’ and Fiasp in iLet Bionic PancreasPurchase Blast
$599
Posted in: SGLT2i Feb 08 | 2019Could Teva Generic Dapa Be Para III? Teva Receives Tentative FDA ApprovalPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, SGLT2i Feb 07 | 2019Sanofi Discontinues 2 Dual-Agonist Programs; Q4 '18 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Insulin Delivery, SGLT2i Feb 06 | 2019No REWIND PRV Mentioned; Lilly Q4 '18 Earnings UpdatePurchase Blast
$599
Posted in: GLP-1RA, Other Feb 05 | 2019Lilly to use PRV for REWIND? Novo Q4 ’18 London earnings updatePurchase Blast
$599
Posted in: Insulin Delivery Feb 05 | 2019BD CY Q4 '18 (FY Q1 '19) Earnings UpdatePurchase Blast
$599
Posted in: Insulin Delivery Feb 04 | 2019JDRF Criticizes Medtronic/UHC For Reducing Patient ChoicePurchase Blast
$599
Posted in: Glucose Monitoring Feb 04 | 2019Senseonics/Roche Renew Distribution Agreement; Acquisition UnlikelyPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal Feb 01 | 2019Novo to File Oral Sema with PRV; Q4 '18 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring Jan 31 | 2019New Roche Smartphone BGM; Q4 '18 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring Jan 31 | 2019Senseonics Receives MRI Approval for Eversense Implantable CGMPurchase Blast
$599
Posted in: Glucose Monitoring, Other Jan 30 | 2019Livongo Acquires Behavioral Health CompanyPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Jan 29 | 2019Lilly Repeatedly Called Out During US Senate Hearing on Drug PricingPurchase Blast